PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
09-Sep-2022 Global Parenteral Nutrition Market Report 2022-2027: Increasing Prevalence of Chronic Diseases Driving Growth - ResearchAndMarkets.com Businesswire
09-Sep-2022 Samenvatting: Studies tonen de effectiviteit aan van AJOVY®▼ (fremanezumab) voor de behandeling van migraine bij patiënten met comorbide depressie Businesswire
09-Sep-2022 Global Generic Drugs Market Report 2022: Aging Population and Increasing Incidences of Chronic Diseases Driving Growth - ResearchAndMarkets.com Businesswire
09-Sep-2022 Clinical Biomarkers Markets, 2031 - ResearchAndMarkets.com Businesswire
09-Sep-2022 Global FLT3 Inhibitors Market Research Report 2022: Focus on Commercialized Therapy & Potential Pipeline Products - ResearchAndMarkets.com Businesswire
09-Sep-2022 The Worldwide Life Science Analytics Software Industry is Expected to Reach $47.8 Billion by 2027 - ResearchAndMarkets.com Businesswire
09-Sep-2022 Global Digital PCR Market Analysis and Forecast, 2022-2032: Rising Awareness of d-PCR-based Diagnostic Testing and Significant Funding for Executing R&D - ResearchAndMarkets.com Businesswire
09-Sep-2022  INCmty Will Celebrate 10 Years at its November Global Entrepreneurship Conference Businesswire
09-Sep-2022 Stevanato Group to Present at Upcoming Investor Conference Businesswire
09-Sep-2022 Global Pharmacovigilance Market Report 2022: Increased Prevalence of ADRs Driving Sector Growth - ResearchAndMarkets.com Businesswire
09-Sep-2022 Macular Degeneration Treatment Global Market Report 2022: Increasing Burden of Retinal Disorders to Bolster Sector Growth - ResearchAndMarkets.com Businesswire
09-Sep-2022 GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Businesswire
09-Sep-2022 Xencor Appoints Nancy Valente, M.D., to Board of Directors Businesswire
09-Sep-2022 InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright 24th Annual Global Investment Conference Businesswire
09-Sep-2022 LYNPARZA® (olaparib) in Combination With Bevacizumab, and as Monotherapy, Demonstrates Clinically Meaningful Long-Term Survival in Certain Patients With First-Line Advanced Ovarian Cancer in Exploratory Analyses of Two Phase 3 Trials Businesswire
09-Sep-2022 Horizon Therapeutics plc Announces $500 Million Share Repurchase Program Businesswire
09-Sep-2022 Global Glass Line Equipment Market Report to 2027 - Featuring DE Ditrich Process Systems, HLE Glascot and Zibo Taiji Industrial Enamel Among Others - ResearchAndMarkets.com Businesswire
09-Sep-2022 NEUWAY Pharma Appoints Healthcare Sector Veteran Dr Jacques Mallet to its Advisory Board Businesswire
09-Sep-2022 Remote Patient Monitoring Devices Thematic Research Report 2022 - ResearchAndMarkets.com Businesswire
09-Sep-2022 Global Doxorubicin Market Analysis Report 2022: A $1.98 Billion Market by 2028 - Increasing Approval of Generic Products - ResearchAndMarkets.com Businesswire